Continuing Education Event – Is Addiction Treatment Effective? Compared to what? How would we know? – Webinar – 7/16/2020
Treatment of Substance Use Disorders has made great strides recently – from changing the way addiction is viewed to the development of new therapies and medications. We will look at the current state of the treatment field and explore the effectiveness of treatment– from examining the public’s expectations of treatment, to studies comparing treatment vs. no treatment, various treatment goals, and the role of motivation in treatment. We look at genetic heritability, twin studies, and predictors of relapse for addiction compared to other chronic medical disorders. Finally, we look at the ways to measure effective care and the argument against defining “total abstinence” as the only form of success.
• Attendees will be able to compare genetic heritability, success rates, and predictors of relapse of individuals with substance use disorders to those with other chronic disorders such as asthma or diabetes.
• Attendees will be able to discuss studies that have shown that motivation for recovery upon entering treatment is not an essential ingredient in predicting outcomes or success.
• Attendees will be able to compare the public’s goals for substance abuse treatment to treatment provider goals.
Recovery Centers of America has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7002. Programs that do not qualify for NBCC credit are clearly identified. Recovery Centers of America is solely responsible for all aspects of the programs. This course qualifies for 1 credit hour.
Deni Carise, Ph.D.
Chief Scientific Officer
Deni Carise, Ph.D. is a Clinical Psychologist and part of the recovery community for over 30 years. She is currently Chief Scientific Officer of Recovery Centers of America (RCA) and Adjunct Assistant Professor at University of Pennsylvania. RCA is dedicated to creating neighborhood-based treatment and recovery campuses that include detoxification, residential, partial hospital, intensive and traditional outpatient, and family services, all available on one campus. Beginning in March 2016, they opened 6 such campuses, 2 in MA and MD, and 1 each in PA and NJ, multiple outpatient programs and one opioid treatment program. Their goal is to get 1 million Americans into meaningful recovery.
Deni has held similar positions at CRC Health Group, providing behavioral health services to more than 42,000 men, women and teens every day at more than140 programs in 33 states and Phoenix House, a nonprofit substance abuse treatment provider with over 100 programs in 10 states where Dr Carise developed national standards for clinical care, Clinical Toolkits for over 30 evidence-based practices, and helped usher in a new era of care to position the company to successfully address changes secondary to healthcare reform. Dr Carise was also Chief Clinical Advisor for Sierra Tucson, a premier facility treating substance abuse, pain, mood, eating and trauma disorders.